Overview
Nettle S.A provides services for the pharmaceutical and healthcare market, supporting manufacturers and pharmacies in pharmaceutical distribution. The company also handles financing and logistics, including direct distribution. It serves more than 15,000 healthcare customers, manages over 1,200 tenders a year, and has more than 9,500 pallet spaces in its warehouses.
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $461 |
Filing timeliness
Financial statements were filed on time, on average 38 days early. All were audited by a statutory auditor.
- 202526/06/2026
- 202412/06/2025
- 202314/06/2024
- 202220/06/2023
- 202130/06/2022
- 202030/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Medicine distribution
- Medical equipment distribution
- Pharmaceutical transport
- Sales handling
- Financial and settlement services
- Pharmaceutical product promotion
- Pharmacy ordering platform
Websites
The company has 4 websites. All of them run on WordPress. The sites are available in: Polish and English. Traffic on the sites is measured with Google Analytics.
- nettle.plStrona główna – Nettle S.AWordPress 6.9ElementorGoogle AnalyticsGoogle Tag ManagerYoast SEOWWPMLApache
- e-dtp.plPlatforma zakupowa eDTP.pl – zamawiaj 24/7WordPress 6.9ElementorGoogle Tag ManagerYoast SEOApache
- magazynimportera.plMagazyn Importera NettleWordPressElementorGoogle Tag ManagerWWPMLApache
Public procurement
165 tenders recorded as contractor: 91 national ($3,048,528) and 74 EU ($4,983,555).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Nov 16, 2026 | Supply of single-use medical equipment | $153.7K$153,724 | Szpital Wojewódzki Im. Prymasa Kardynała Stefana Wyszyńskiego w Sieradzu | |
| Nov 13, 2026 | Supply of a contrast injector for Zakład Radiologii Klinicznej SKDJ | $31,073$31,073 | Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego | |
| Nov 10, 2026 | 40/D/26 Supply of medical equipment and apparatus, lot 3 | $26,861$26,861 | Samodzielny Publiczny Zakład Opieki Zdrowotnej Ministerstwa Spraw Wewnętrznych i Administracji w Łodzi |
The company is the contractor in 28 public sector contracts, worth USD 789.12k in total. They were signed with 23 public buyers.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Nov 13, 2026 | Supply of medical materials: sets for contrast agent administration | $8,104 | Samodzielny Publiczny Zakład Opieki Zdrowotnej Wojewódzki Szpital Specjalistyczny Nr 3 w Rybniku | |
| Nov 10, 2026 | Lot 20. Concerning procedure no. ZP 58/26 | $40,288 | Szpital Kliniczny Im. Karola Jonschera Uniwersytetu Medycznego Im. Karola Marcinkowskiego w Poznaniu | |
| Nov 9, 2026 | DZPUCK.262.193.753.2026 | $31,073 | Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego |
Nettle has been a party to 2 cases before the National Appeal Chamber (since 2013). In 2 cases it joined the proceedings as a participant.
| Date | Subject of dispute | Outcome | Other party | |
|---|---|---|---|---|
| Jul 29, 2026 | Rejection of the tender | Upheld | Samodzielny Publiczny Wielospecjalistyczny Zakład Opieki Zdrowotnej w Stargardzie | |
| Aug 14, 2013 | Explanation of the reservation of information as a trade secret | Upheld | Wojewódzki Szpital Specjalistyczny im. Mikołaja Kopernika |
Trademarks
The company holds 2 active trademarks registered with the Polish Patent Office. The first mark was filed in 2020.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| NETTLE | Z.511663 | 16, 35, 36, 39, 41 | Protected | Mar 19, 2030 | |
| NETTLE | Z.511666 | 16, 35, 36, 39, 41 | Protected | Mar 19, 2030 |
| Mark | Protected until | |
|---|---|---|
| NETTLE | Mar 19, 2030 | |
| NETTLE | Mar 19, 2030 |
Job offers
The company has its own careers page: nettle.pl/o-nas.
Authorized Representatives
Manner of representation
In the case of a one-person management board, the sole member of the management board is independently authorized to make declarations of will and sign on behalf of the company. In the case of a multi-member management board, joint action by two members of the management board acting jointly or by a member of the management board acting jointly with a commercial proxy is required to make declarations of will and sign on behalf of the company, provided that the manner in which the commercial proxy is granted permits such joint action.
Supervisory board
Ownership
| Owner |
|---|
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2006-06-06.
96 1540 1030 2103 1218 9274 0002
42 1540 1030 2103 1218 9274 0004
62 1600 1462 1817 2620 4000 0007
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Investment property | PLN 5.5MPLN 5,511,853 |
Public aid
8 public aid cases recorded, with a total value of $1,092,769.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 9, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | PGE Obrót S.A. | |
| Dec 21, 2023 | Liquidity support for undertakings affected by the war in Ukraine | –– | Prezes Banku Gospodarstwa Krajowego | |
| Jul 7, 2023 | Liquidity support for undertakings affected by the war in Ukraine | –– | Prezes Banku Gospodarstwa Krajowego |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Novo S.A. | $209,522,261.96 | novo-sa.pl | ||
| Producencka Centrala Farmaceutyczna Procefar sp. z o.o. | $140,213,508.12 | procefar.pl | ||
| Phoenix Pharma Polska sp. z o.o. | $140,768,509.34 | phoenixpharma.pl | ||
| Pelion S.A. | $99,756,667.36 | pelion.eu | ||
| Magnapharm Poland sp. z o.o. | $90,512,785.67 | magnapharm.pl | ||
| Dospiro sp. z o.o. | $67,870,706.01 | dospiro.pl | ||
| Cefarm Białystok S.A. | $50,062,782.52 | farmacol.com.pl | ||
| Vantage Trading sp. z o.o. | $24,835,003.93 | vantages.pl | ||
| Midas Pharma Polska sp. z o.o. | $20,847,894.51 | midas-pharma.com | ||
| Medyk-Lek Panek sp. z o.o. sp. k. | $20,167,374.20 | medyklek.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-07-07 | PKD change (Removed: 4 codes; Added: 4 codes) | |
| 2020-06-19 | PKD change (Removed: 68.10.Z, 68.20.Z, 73.20.Z, 85.59.B, 96.09.Z; Added: 49.41.Z) | |
| 2020-03-30 | PKD change (Added: 46.46.Z) | |
| 2018-03-12 | Share capital increase (7,500,000.00 PLN → 10,001,330.00 PLN) | |
| 2013-09-12 | Share capital increase (3,500,000.00 PLN → 7,500,000.00 PLN) |
FAQ
Last updated: 2026-08-21
